5-hydroxy-2-n,n-dipropylaminotetralin has been researched along with pirimicarb in 1 studies
| Studies (5-hydroxy-2-n,n-dipropylaminotetralin) | Trials (5-hydroxy-2-n,n-dipropylaminotetralin) | Recent Studies (post-2010) (5-hydroxy-2-n,n-dipropylaminotetralin) | Studies (pirimicarb) | Trials (pirimicarb) | Recent Studies (post-2010) (pirimicarb) |
|---|---|---|---|---|---|
| 42 | 0 | 3 | 110 | 1 | 45 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christian, BT; Mukherjee, J; Narayanan, TK; Shi, B; Yang, ZY | 1 |
1 other study(ies) available for 5-hydroxy-2-n,n-dipropylaminotetralin and pirimicarb
| Article | Year |
|---|---|
Binding characteristics of high-affinity dopamine D2/D3 receptor agonists, 11C-PPHT and 11C-ZYY-339 in rodents and imaging in non-human primates by PET.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain; Brain Chemistry; Brain Mapping; Carbamates; Carbon Isotopes; Corpus Striatum; Guanylyl Imidodiphosphate; In Vitro Techniques; Inhibitory Concentration 50; Macaca mulatta; Male; Phenethylamines; Positron-Emission Tomography; Pyrimidines; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Time Factors; Tissue Distribution | 2004 |